Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06017297
Status:
RECRUITING
Last Update Posted:
2024-04-24
First Post:
2023-08-24
Brief Title:
Neoadjuvant Tremelimumab and Durvalumab With GemCis in Intrahepatic Cholangiocarcinoma
Sponsor:
Georgetown University
Organization:
Georgetown University
Organization Data
Organization:
Georgetown University
Class:
OTHER
Study ID:
STUDY00006462
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Georgetown University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |